Our Speakers



Professor Nawab Qizilbash, MBChB MRCP (UK) BSc MSc DPhil (Oxon.)

Nawab Qizilbash is Clinical Epidemiologist & Head of OXON Epidemiology, Joint Coordinator of the ENCePP Special Interest Group on Impact of PV Activities and:

  • Honorary Senior Lecturer in Epidemiology, London School of Hygiene and Tropical Medicine, London University
  • Honorary Consultant Geriatrician, Hospital Cantoblanco, Madrid
  • Member of Green Templeton College, Oxford University
  • Co-author of x7 Lancet, x1 JAMA and x3 BMJ publications in epidemiology, pragmatic trials and meta-analysis
  • Chief editor of 'Evidence-based Dementia Practice' published by Blackwells, Oxford.

Former Nawab was Director of Epidemiology and Evidence-based Medicine, GSK (1997-2005); he trained under and worked with Professor Sir Richard Peto F.R.S., and was founding editor of the Cochrane Dementia Group. He also trained in general internal medicine and geriatrics under Professor Sir John Grimley Evans and was Honorary Consultant Physician at the Radcliffe Infirmary, Oxford (1997-2000), and St's Mary's Hospital, London (2005-2006).

Among CROs in Europe, Nawab provides clients with a unique combination of high quality epidemiological and clinical experience covering many therapeutic areas.

Nicholas Moore

March 13, 2019

Professor Nicholas Moore, MD, PhD, FRCP (Edin)

FISPE, Honorary Member ISOP, Chevalier dans l'ordre National des Palmes Académiques Nicholas Moore is Head of the department of Pharmacology in Bordeaux,

a 100+ strong department with teams working in experimental pharmacology, therapeutic drug monitoring and toxicology, in pharmacovigilance and pharmacoepidemiology (an ENCEPP centre), in clinical pharmacology.

He is head of the Clinical Investigation Centre, in Bordeaux for interventional and observational research. Nicholas Moore was born in New York, USA in 1953, and has dual French-US citizenship. He did his medical studies in Paris then trained in cardiology and pharmacology in Rouen. He spent dozen years more in Rouen in Clinical Pharmacology and Pharmacovigilance, during which time he became vice-president of the French Association of Regional Pharmacovigilance Centres, and founded the European Society of Pharmacovigilance. He moved to Bordeaux in 1996 as Professor of Clinical Pharmacology.

He was Coordinator of Clinical Research for the university hospital in Bordeaux and for the South-west and Overseas region of France (2003-2011). He was president of ISOP, the International Society of Pharmacovigilance, from 2006 to 2009, Vice-Chairman of the European Association of Clinical Pharmacology and Therapeutics from 2003 to 2011, Director of the International Society of Pharmacoepidemiology (ISPE) from 2003 to 2011, and is a member of the ENCEPP Steering Committee.

He has co-authored over 400 papers in peer-reviewed journals.

Tom MacDonalds

April 25, 2019

Professor Thomas MacDonald, BSC, MBCHB, MD

Professor of Clinical Pharmacology & Pharmacoepidemiology in the Medical Research Institute, University of Dundee, and Honorary Consultant Physician at Ninewells Hospital and Medical School.

His research interests are hypertension, cardiovascular disease, pharmacoepidemiology and drug safety and innovative trial designs. He is the immediate past president of the British Hypertension Society, a past president of the International Society of Pharmacoepidemiology and the current director of the Tayside Medicines Monitoring Unit (MEMO) which has access to the MEMO database and to the CPRD database. He is an elected member of the steering committee of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance.

Professor MacDonald has published extensively on drug safety especially the safety of non-steroidal anti-inflammatory drugs (NSAIDs). He has also published many studies of hypertension and other cardiovascular risk factors and cardiovascular disorders.

Carlo Giaquinto

May 16, 2019

Professor Carlo Giaquinto, MD

Department of Paediatrics at the University of Padova,

Carlo Giaquinto is head of several organisations including, Head of the Referral Centre for Paediatric HIV infection at the Department of Paediatrics of the University of Padua since 1993, Head of the Paediatric European network treatment AIDS (PENTA network) since 1994 and co-chair of the EU funded Network of Excellence TEDDY (Task Force in Europe for Drug Development in the Young). He is also president of the PENTA foundation and chairman of the Paediatric Rotavirus European Committee (PROTECT) group. He is also the chair of the GRIP project (Global Research in Pediatrics) an EU funded network of Excellence.

Dr. Giaquinto is coordinator for various projects including the social AIDS projects financed by the European Community and by other international organisations both in Europe and Africa. He is coordinator of Pedianet: a primary care paediatric database. He has served as honorary senior lecturer in the centre for paediatric epidemiology and biostatistics of the Institute of Child Health in London since 2002.

He is Author of more than 180 publications in peer-reviewed journals and has been invited as speaker at more than 300 conferences and international workshops across the world.


June 2019 (date tbc)

Professor Vera Ehrenstein, MPH, DSc

Professor at the Department of Clinical Epidemiology Aarhus University, Denmark, responsible for post marketing studies.

Vera Ehrenstein coordinates several international pharmacoepidemiology, pharmacovigilance and clinical epidemiology studies in collaboration with industry or regulators. She is a member of the ENCePP Steering Committee and serves as the 2016-2017 Chair of the Academic Council at the International Society of Pharmacoepidemiology. She earned a doctorate in epidemiology in 2008, and an MPH in epidemiology and biostatistics in 2000, from Boston University.

Vera Ehrenstein has co-authored a book chapter and published about 80 peer-reviewed papers within the fields of clinical epidemiology, pharmacoepidemiology and fetal origins of adult disease.


July 2019 (date tbc)

Dr Niklas Schmedt, DrPH 

Niklas is head of the “Health Services Research and Pharmacoepidemiology” unit at InGef – Institute for Applied Health Research Berlin and holds a Doctor of Public Health degree (2016) from the University of Bremen.

After his master’s degree in public health in 2012 at the University of Bremen, he worked as research associate at the “Drug Safety” unit of the Leibniz Institute for Prevention Research and Epidemiology – BIPS at Bremen and completed intermediate and advanced courses in Pharmacoepidemiology at McGill University in Montréal. Since 2016, he is working at the InGef – Institute for Applied Health Research in Berlin. His scientific focus is on health services research and pharmacoepidemiology based on large German claims databases. He is vice-chair of the pharmacoepidemiology working group of the German Society of Epidemiology and member of the editorial board of GMS Medical Informatics, Biometry and Epidemiology (MIBE).


September 2019 (date tbc)

Dr Ana Filipa Macedo, PharmD PhD

Director of Epidemiology at OXON

Ana Filipa Macedo holds a Pharmaceutical degree and a PhD in Pharmacoepidemiology. She has more than 17 years of experience in the design and conduct of studies using primary data collection and secondary data sources. She has worked across various therapeutic areas, in the design of observational studies on the natural history of disease and comparative safety and effectiveness of medical treatments.

Ana Filipa was a research fellow at the London School of Hygiene and Tropical Medicine, where she worked with Prof. Liam Smeeth and Ian Douglas in studies using CPRD; and joined the Cochrane Heart group, working with Prof. Shah Ebrahim in the conduct of numerous systematic reviews and meta-analyses. Ana Filipa also worked in the Pharmaceutical Industry in the UK, being responsible for the evidence synthesis required for health technology appraisals, including network meta-analyses. She is co-author of the book chapter “Primary data collection for Pharmacoepidemiology” in Brian Strom’s textbook “Pharmacoepidemiology”. 20018 (In Press).


October 2019 (date tbc)

Professor Masao Iwagami, MD, MPH, MSc, PhD

Masao Iwagami is a Clinical Epidemiologist and Assistant Professor in the Department of Health Services Research, University of Tsukuba, Japan. He graduated from the University of Tokyo in 2008, completed his internship and residency in Japanese hospitals, and worked as a Research Assistant Professor in the Department of Hemodialysis and Apheresis, the University of Tokyo Hospital in 2013.

He formally studied clinical epidemiology and pharmacoepidemiology at the School of Public Health, the University of Tokyo in 2012, at MSc Epidemiology in 2013/2014, Pharmacoepidemiology and Pharmacovigialnce short course in 2017/2018, and PhD Epidemiology and Population Health in 2014-2018 at London School of Hygiene & Tropical Medicine. He is well experienced in conducting medical research using large databases of routinely collected data, such as UK Clinical Practice Research Datalink (CPRD), Japanese Diagnosis Procedure Combination (DPC) Database, Medical Data Vision (MDV) Database, and Japan Medical Data Center Database (JMDC).


October 2019 (date tbc)

Professor Yea-Huei Kao Yan

Dr. Yea-Huei Kao Yang is affiliated to  National Cheng Kung University. Dr. Yea-Huei Kao Yang is currently providing services as J186.

Dr. Yea-Huei Kao Yang has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Yea-Huei Kao Yang contributions have acclaimed recognition from honourable subject experts around the world. Dr. Yea-Huei Kao Yang is actively associated with different societies and academies. Dr. Yea-Huei Kao Yang academic career is decorated with several reputed awards and funding. Dr. Yea-Huei Kao Yang research interests include Clinical Pharmacy,  and Pharmacoepidemiology.


November 2019 (date tbc)

Dr Ju-Young Shin 

Ju-Young Shin is a current assistant professor at school of pharmacy, SungKyunKwan University (SKKU). She also serves as an associate editor of Pharmacoepidemiolgoy and Drug Safety (PDS). She received her B.S. in pharmacy from Seoul National University, MPH in health policy and Ph.D. in pharmacoepidemiology from the Seoul National University College of Medicine. She was a visiting fellow at university of South Australia, and postdoctoral fellow at McGill University.

She published more than 90 peer-reviewed journal and published her study in British Medical Journal (BMJ), twice, regarding the safety of antidepressants and ADHD medication using 50 million Korean healthcare databases. Her area of research is a safety of psychotropic drugs, vaccine safety, methodology development, and drug utilization review in the frail population. She is leading or co-leading several projects sponsored by Korea Ministry of Food and Drug Safety, Ministry of Health and Welfare, Center for Disease Control and Prevention, National Research Foundations, and Pharmaceutical companies.

She was a past-team director at Korea Institute of Drug Safety and Risk Management (KIDS) and led several epidemiological studies. She is now in charge of vice-director in one of Korean regional pharmacovigilance center- pharmacist association. She also serves as a consultant for several Korean governmental committee including national evidence-based collaborating agency (NECA), and KIDS. She has been a member of International Society for Pharmacoepidemiology (ISPE) since 2007 and is currently a member of board of directors of Korea society of Pharmacoepidemiology and Risk Management (KoPERM), Korea society of epidemiology, and Korea academy of social and managed care pharmacy.